AGTR1 and Obesity: In obesity-induced hypertensive rats, telmisartan could also inhibit AT1 receptor-induced oxidative stress in the RVLM and activation of the SNS to a greater extent than losartan, in spite of similar depressor effects (Konno et al., 2012).